Expiration date: 02/2024
The composition and form of issue:
1 tablet contains of biperiden hydrochloride 2 mg blister 10 or 20 PCs., in box 10, or 5 blisters respectively.
1 vial 1 ml solution for injection — biperiden lactate 5 mg in a box 5 PCs
Blocks the Central m-cholinergic receptors inhibits m-cholinergic (mainly type M1) the transfer of excitation in the autonomic nervous system.
Parkinson's syndrome, extrapyramidal disorders due to medications (neuroleptics).
Angle-closure glaucoma, megacolon, and mechanical stenosis of the gastrointestinal tract. Relatively contraindicated in prostatic hypertrophy, tachyarrhythmias.
Application of pregnancy and breast-feeding:
Violation ccomodation, dry mouth, diarrhoea disorders, tachycardia, demotion AD fatigue, dizziness, drowsiness, confusion.
Enhances neurotrophic effects of anticholinergics, antihistamines, antiparkinson and anticonvulsant agents. Incompatible with alcohol. When co-administered with quinidine may increase anticholinergic action, with levodopa increases the risk of developing dyskinesia.
Method of application and dose:
Inside, in/in or/m. Dosage and frequency of administration are variable, and depend on the indications and patient's age.
To prevent side effects, the dose should be increased gradually to avoid abrupt discontinuation of the drug. During treatment is not recommended management of vehicles and mechanisms.
After preparation - 24 hours